Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Erb

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
The American Journal of Pathology|August 21, 2024
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate CancerMaximilian P Brandt, Olesya Vakhrusheva, Hubert Hackl, et al.
Oncogene|May 15, 2024
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancerAlicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, et al.
Oncogene|November 28, 2023
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblastsAndrea Eigentler, Florian Handle, Silvia Schanung, et al.
Frontiers in Oncology|February 24, 2022
Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer CellsOlesya Vakhrusheva, Holger H H Erb, Vitus Bräunig, et al.
Oncotarget|March 10, 2015
Mechanistic rationale for MCL1 inhibition during androgen deprivation therapyFrédéric R Santer, Holger H H Erb, Su Jung Oh, et al.
Scientific Reports|March 28, 2019
The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancyRobert I Seed, Alberto J Taurozzi, Daniel J Wilcock, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 16, 2024
Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor SymposiumJustus Simon Israel, Laura-Maria Marcelin, Christian Thomas, et al.
Theranostics|January 3, 2024
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcriptionIelizaveta Gorodetska, Anne Offermann, Jakob Püschel, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
The American Journal of Pathology|August 21, 2024
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate CancerMaximilian P Brandt, Olesya Vakhrusheva, Hubert Hackl, et al.
Oncogene|May 15, 2024
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancerAlicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, et al.
Oncogene|November 28, 2023
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblastsAndrea Eigentler, Florian Handle, Silvia Schanung, et al.
Frontiers in Oncology|February 24, 2022
Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer CellsOlesya Vakhrusheva, Holger H H Erb, Vitus Bräunig, et al.
Oncotarget|March 10, 2015
Mechanistic rationale for MCL1 inhibition during androgen deprivation therapyFrédéric R Santer, Holger H H Erb, Su Jung Oh, et al.
Scientific Reports|March 28, 2019
The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancyRobert I Seed, Alberto J Taurozzi, Daniel J Wilcock, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 16, 2024
Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor SymposiumJustus Simon Israel, Laura-Maria Marcelin, Christian Thomas, et al.
Theranostics|January 3, 2024
ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and RAR-dependent transcriptionIelizaveta Gorodetska, Anne Offermann, Jakob Püschel, et al.
Pageof 11